Since the depletion of MDSCs and TAMs was anticipated to result in an increase in the Teff response to the 4T1 tumor, we investigated the effect of DABIL‐4 administration upon both CD4+ and CD8+ lymphocytes in 4T1 tumor‐bearing mice. The gene discussed is CD8A; the disease is neoplasm.